1. Home
  2. CLNN vs KFFB Comparison

CLNN vs KFFB Comparison

Compare CLNN & KFFB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLNN
  • KFFB
  • Stock Information
  • Founded
  • CLNN 2012
  • KFFB 2005
  • Country
  • CLNN United States
  • KFFB United States
  • Employees
  • CLNN N/A
  • KFFB N/A
  • Industry
  • CLNN Biotechnology: Pharmaceutical Preparations
  • KFFB Savings Institutions
  • Sector
  • CLNN Health Care
  • KFFB Finance
  • Exchange
  • CLNN Nasdaq
  • KFFB Nasdaq
  • Market Cap
  • CLNN 23.1M
  • KFFB 21.0M
  • IPO Year
  • CLNN N/A
  • KFFB 2005
  • Fundamental
  • Price
  • CLNN $3.70
  • KFFB $3.03
  • Analyst Decision
  • CLNN Strong Buy
  • KFFB
  • Analyst Count
  • CLNN 5
  • KFFB 0
  • Target Price
  • CLNN $40.00
  • KFFB N/A
  • AVG Volume (30 Days)
  • CLNN 56.5K
  • KFFB 6.4K
  • Earning Date
  • CLNN 08-06-2025
  • KFFB 05-12-2025
  • Dividend Yield
  • CLNN N/A
  • KFFB N/A
  • EPS Growth
  • CLNN N/A
  • KFFB N/A
  • EPS
  • CLNN N/A
  • KFFB N/A
  • Revenue
  • CLNN $350,000.00
  • KFFB $8,308,000.00
  • Revenue This Year
  • CLNN N/A
  • KFFB N/A
  • Revenue Next Year
  • CLNN $1,753.57
  • KFFB N/A
  • P/E Ratio
  • CLNN N/A
  • KFFB N/A
  • Revenue Growth
  • CLNN N/A
  • KFFB 13.79
  • 52 Week Low
  • CLNN $2.28
  • KFFB $1.96
  • 52 Week High
  • CLNN $6.96
  • KFFB $3.62
  • Technical
  • Relative Strength Index (RSI)
  • CLNN 46.64
  • KFFB 65.38
  • Support Level
  • CLNN $3.53
  • KFFB $2.91
  • Resistance Level
  • CLNN $3.81
  • KFFB $3.03
  • Average True Range (ATR)
  • CLNN 0.21
  • KFFB 0.10
  • MACD
  • CLNN -0.07
  • KFFB 0.02
  • Stochastic Oscillator
  • CLNN 24.64
  • KFFB 90.48

About CLNN Clene Inc.

Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.

About KFFB Kentucky First Federal Bancorp

Kentucky First Federal Bancorp is a holding company. The company through its subsidiaries is engaged mainly in the business of accepting deposits from the general public and using such funds to originate loans secured by first mortgages on owner-occupied, residential real estate and other loans secured by real estate. Its primary products and services include Residential mortgage loans, Multi-family loans, Construction loans and types of deposits, etc. The company mainly operates in Perry, Franklin, Boyle and Garrard and surrounding counties in Kentucky, US.

Share on Social Networks: